U.S. Physical Therapy, Inc. reported strong first quarter 2025 results with a significant increase in net income and revenue, primarily due to recent acquisitions and improved net patient revenue per visit, despite a Medicare rate reduction.

U.S. Physical Therapy reported strong financial results for the fourth quarter and full year 2024, with significant increases in net patient revenue and gross profit. The company achieved record quarterly patient volume and expanded its clinic count through strategic acquisitions, despite challenges from Medicare reimbursement reductions.

U.S. Physical Therapy's Q4 2023 saw a revenue increase of 9.6% to $154.8 million, driven by record patient volume, but net income decreased to $0.7 million due to a non-cash impairment charge. Loss per share was $0.38.

U.S. Physical Therapy reported a 7.5% increase in total net revenue to $150.0 million, driven by a 9.0% increase in net patient revenue from physical therapy operations. The company achieved a record-high average visits per clinic per day for a third quarter, with total patient visits up 10.8%. EPS was $0.51, and non-GAAP Operating Results per share were $0.62.

U.S. Physical Therapy reported a 7.7% increase in total net revenue to $151.5 million, driven by record patient volumes and new clinic additions, although net income decreased due to higher interest expenses. Management reaffirmed its Adjusted EBITDA guidance for 2023.

U.S. Physical Therapy reported a strong first quarter in 2023, marked by record-high first quarter volume and Adjusted EBITDA, despite a decrease in net income primarily due to increased interest expenses.

U.S. Physical Therapy reported an increase in revenue but a decrease in net income for Q4 2022. Revenue increased by 8.7% compared to Q4 2021, while net income decreased due to a goodwill impairment charge. The company's Board of Directors raised the quarterly dividend by 4.9%.

U.S. Physical Therapy reported a 10.9% increase in total revenue to $139.6 million for Q3 2022 compared to Q3 2021. Net income attributable to shareholders was $9.6 million, and earnings per diluted share were $0.72. The company faced higher labor and operating costs due to inflation, and volumes were slightly impacted by Hurricane Ian.

U.S. Physical Therapy reported a 10.8% increase in total revenue to $140.7 million for the second quarter of 2022, driven by growth in physical therapy operations and industrial injury prevention services. However, net income attributable to USPH shareholders decreased to $11.2 million, and operating income also saw a decrease.

U.S. Physical Therapy reported a 17.2% increase in total revenue to $131.7 million for Q1 2022, driven by growth in physical therapy operations and industrial injury prevention services. Net income attributable to USPH shareholders was $8.8 million, up from $8.2 million in Q1 2021. The company's adjusted EBITDA increased by 14.2% to $17.9 million.

U.S. Physical Therapy reported a strong fourth quarter and full year 2021, marked by record patient volumes and significant growth in industrial injury prevention services. Total revenue for the quarter increased by 10.5% compared to the previous year, and the company provided positive earnings guidance for 2022.

U.S. Physical Therapy reported strong Q3 2021 results with revenue up 15.6% year-over-year, driven by robust patient volumes. The company's net income attributable to USPH shareholders was $10.0 million, and adjusted EBITDA, excluding Relief Funds, was $19.9 million, a 1.8% increase compared to the same period last year.

U.S. Physical Therapy reported record-high net revenues and average visits per clinic per day for the second quarter of 2021. Management raised earnings guidance and increased the quarterly dividend due to the Company's strong performance.

U.S. Physical Therapy reported strong first-quarter earnings, driven by increased patient volumes and effective cost management. The company's Operating Results per share increased, and Adjusted EBITDA saw significant growth. Management also revised upwards its 2021 earnings guidance.

U.S. Physical Therapy's Q4 2020 results showed a net revenue of $117.5 million compared to $122.1 million in Q4 2019. Net income attributable to USPH shareholders was $13.0 million, or $0.68 per share, as compared to $7.9 million, or $0.55 per share in Q4 2019. The company reinstated its quarterly dividend and provided 2021 earnings guidance.

U.S. Physical Therapy reported record quarterly earnings with net revenues of $108.9 million and net income attributable to USPH shareholders of $10.9 million, or $0.61 per share.

U.S. Physical Therapy reported a decrease in net revenues for the second quarter of 2020 compared to the same period in 2019, primarily due to the adverse effects of the COVID-19 pandemic. However, the company's physical therapy daily patient volumes improved throughout the quarter, and the industrial injury prevention business remained relatively stable.

U.S. Physical Therapy reported first quarter earnings for 2020, which were negatively impacted by the COVID-19 pandemic, with an estimated loss of more than $8 million in revenue and related contribution margin. The company experienced significantly lower physical therapy revenue and expects to incur losses in the near term. Management has taken steps to mitigate operating losses through furloughs, salary cuts, and expense reductions.

U.S. Physical Therapy reported a 4.1% increase in net revenues for Q4 2019, reaching $122.1 million, driven by growth in net patient revenues and the industrial injury prevention business. Operating income also rose by 3.3% to $15.3 million. However, the company faced challenges with higher employee healthcare costs, impacting overall profitability.